YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
860Patents
470Active
860Granted
55Portfolio score
Filing activity: Feb 28, 1974 → Jul 7, 2024 · 157 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5192549A | Method of amphiphatic drug loading in liposomes by pH gradient | Emerging Cross-Sectional Technologies | 263 | Expired |
| US5316771A | Method of amphiphatic drug loading in liposomes by ammonium ion gradient | Emerging Cross-Sectional Technologies | 239 | Expired |
| US5023082A | Sustained-release pharmaceutical compositions | Human Necessities | 211 | Expired |
| US5443701A | Electrobiochemical analytical method and electrodes | Emerging Cross-Sectional Technologies | 202 | Expired |
| US5217999A | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | Chemistry; Metallurgy | 183 | Expired |
| US5364632A | Medicinal emulsions | Human Necessities | 177 | Expired |
| US8163077B2 | Ink providing etch-like effect for printing on ceramic surfaces | Emerging Cross-Sectional Technologies | 132 | Active |
| US7456154B2 | Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof | Chemistry; Metallurgy | 118 | Active |
| US4797285A | Lipsome/anthraquinone drug composition and method | Emerging Cross-Sectional Technologies | 102 | Expired |
| US6692766B1 | Controlled release oral drug delivery system | Human Necessities | 101 | Expired |
| US5789427A | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 95 | Expired |
| US6011008A | Conjugates of biologically active substances | Human Necessities | 93 | Expired |
| US4926479A | Multiprover interactive verification system | Electricity | 91 | Expired |
| US6703660B2 | Hybrid electrical device with biological components | Electricity | 91 | Expired |
| US5716638A | Composition for applying active substances to or through the skin | Human Necessities | 89 | Expired |
| US5851999A | FLK-1 is a receptor for vascular endothelial growth factor | Physics | 88 | Expired |
| US5630978A | Preparation of biologically active molecules by molecular imprinting | Emerging Cross-Sectional Technologies | 87 | Expired |
| US5773476A | Methods and compositions for inhibiting cell proliferative disorders | Chemistry; Metallurgy | 85 | Expired |
| US5792771A | Quinazoline compounds and compositions thereof for the treatment of disease | Physics | 82 | Expired |
| US6331555A | Treatment of platelet derived growth factor related disorders such as cancers | Human Necessities | 81 | Expired |
| US6316098A | Molecular layer epitaxy method and compositions | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5700823A | Treatment of platelet derived growth factor related disorders such as cancers | Emerging Cross-Sectional Technologies | 76 | Expired |
| US6685962B2 | Gastroretentive controlled release pharmaceutical dosage forms | Human Necessities | 76 | Expired |
| US5874529A | Conformationally constrained backbone cyclized peptide analogs | Emerging Cross-Sectional Technologies | 73 | Expired |
| US6198852A | View synthesis from plural images using a trifocal tensor data structure in a multi-view parallax geometry | Physics | 70 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.